A bacterium makes a molecule that kills drug-resistant fungi in an unusual way — by targeting various phospholipid molecules ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

Olpasiran leads to significant and sustained reduction in oxidized phospholipids on apolipoprotein B. HealthDay News — Olpasiran, a small interfering RNA, which blocks lipoprotein(a ...

A new study published in the Journal of American Medical Association showed that the innovative small interfering RNA (siRNA) medication olpasiran (Amgen) can effectively reduce lipoprotein(a) ...

The ability of bacteria to control the biophysical properties of their membrane phospholipids allows them to thrive in a wide range of physical environments. Fatty acid biosynthesis is an energy ...

Joining Forces with Zillion Fine Chemicals to Expand CDMO BusinessTAIPEI, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Amaran Biotechnology I ...

leads to a significant and sustained reduction in oxidized phospholipids (OxPL) on apolipoprotein B (apoB), according to a study published online Feb. 12 in JAMA Cardiology. Robert S. Rosenson ...